非侵袭性血浆游离DNA与侵袭性诊断对侵袭性真菌病诊断的一致性
这项回顾性单中心队列研究纳入506例在侵袭性标本采集前7天或后2天完成霉菌血浆游离DNA聚合酶链反应(PCR)的患者,其中437例(86.4%)为免疫功能低下者。经欧洲癌症研究与治疗组织和真菌研究组教育与研究联盟侵袭性霉菌病定义裁定不一致结果后,霉菌血浆游离DNA PCR与侵袭性标本真菌检测结果的一致性为88.5%(448/506)。作者认为非侵袭性霉菌血浆游离DNA PCR结果与侵袭性标本真菌检测结果高度一致,提示在疑似侵袭性霉菌病的免疫功能低下患者中可安全减少有风险倾向的侵袭性标本采集。
要点
- 霉菌血浆游离DNA PCR与侵袭性标本真菌检测结果的一致性为88.5%(448/506)。
- 在确诊病例中,64.7%(11/17)的霉菌血浆游离DNA PCR阴性结果见于真菌性鼻窦炎(8例)和肢体感染(3例)患者。
- 非血液系统恶性肿瘤和非中性粒细胞减少状态与确诊或临床诊断侵袭性霉菌病患者的霉菌血浆游离DNA PCR阴性结果有统计学关联。
核心结论
- 非侵袭性霉菌血浆游离DNA PCR结果与侵袭性标本真菌检测结果高度一致,提示在疑似侵袭性霉菌病的免疫功能低下患者中可安全减少有风险倾向的侵袭性标本采集。
研究设计与样本
- 回顾性单中心队列研究,纳入在侵袭性标本采集前7天或后2天完成霉菌血浆游离DNA PCR的患者。
- 共纳入506例患者,侵袭性标本包括组织活检和支气管镜检查,其中组织标本123例、支气管肺泡灌洗液426例。
- 437例(86.4%)为免疫功能低下者。
- 霉菌PCR检测曲霉属、毛霉目病原、镰刀菌属和足放线菌属。
- 主要终点为霉菌血浆游离DNA PCR结果与组织和支气管肺泡灌洗液常规真菌检测结果的一致性。
主要发现
- 经欧洲癌症研究与治疗组织和真菌研究组教育与研究联盟侵袭性霉菌病定义裁定不一致结果后,霉菌血浆游离DNA PCR与侵袭性检测结果的一致性为88.5%(448/506)。
- 在确诊病例中,64.7%(11/17)的霉菌血浆游离DNA PCR阴性结果见于真菌性鼻窦炎(8例)和肢体感染(3例)患者。
- 在确诊或临床诊断侵袭性霉菌病患者中,非血液系统恶性肿瘤和非中性粒细胞减少状态与霉菌血浆游离DNA PCR阴性结果有统计学关联。
关键数值与推荐
- 一致性判定依据欧洲癌症研究与治疗组织和真菌研究组教育与研究联盟侵袭性霉菌病定义裁定不一致结果。
- 霉菌血浆游离DNA PCR与侵袭性检测结果一致性为88.5%(448/506)。
- 确诊病例中霉菌血浆游离DNA PCR阴性结果占64.7%(11/17),其中真菌性鼻窦炎8例、肢体感染3例。
临床怎么用
- 作者认为非侵袭性霉菌血浆游离DNA PCR结果与侵袭性标本真菌检测结果高度一致,提示在疑似侵袭性霉菌病的免疫功能低下患者中可安全减少有风险倾向的侵袭性标本采集。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mold plasma cell-free DNA (cfDNA) polymerase chain reaction (PCR) is a promising noninvasive diagnostic modality for early diagnosis of invasive mold disease (IMD) in immunocompromised patients. Although mold cfDNA PCR has been shown to be highly accurate, the value of invasive procedures to collect specimens for conventional fungal diagnostics following plasma cfDNA testing remains unclear. METHODS: This retrospective single-center cohort study included patients with mold plasma cfDNA PCR performed 7 days before or 2 days after invasive specimen collection. Mold PCR detected Aspergillus species, Mucorales agents, Fusarium species, and Scedosporium species. Invasive procedures included tissue biopsy and bronchoscopy. The primary endpoint was the concordance of mold plasma cfDNA PCR results with results of conventional fungal tests performed on tissue and bronchoalveolar lavage fluid. RESULTS: Five hundred and six patients with mold plasma cfDNA PCR resulting ahead of invasive specimen (123 tissue and 426 bronchoalveolar lavage fluid) results were included, and 437 (86.4%) were immunocompromised. After adjudicating discordant results based on the European Organization for Research and Treatment of Cancer and Mycoses Study Group Education and Research Consortium definitions for IMD, mold plasma cfDNA PCR and invasive test results were 88.5% (448/506) concordant. In proven cases, 64.7% (11/17) of negative mold plasma cfDNA PCR results occurred in patients with fungal sinusitis (8) and limb infection (3). Nonhematologic malignancy and nonneutropenic state were statistically associated with negative mold plasma cfDNA PCR in patients with proven or probable IMD. CONCLUSIONS: Noninvasive mold plasma cfDNA PCR results were highly concordant with invasive specimen fungal test results, indicating risk-prone invasive specimen collection can be safely curtailed in immunocompromised patients with suspected IMD.
引用
- Lieu A, Zimmet AN, Pozdol J, et al. Concordance of Noninvasive Plasma Cell-free DNA With Invasive Diagnostics for Diagnosis of Invasive Fungal Disease. Clin Infect Dis. 2025. PMID: 39823293. doi:10.1093/cid/ciaf021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。